Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4866435

O=C(O)C(F)(F)F.Oc1ccc(SC2CCNCC2)cc1

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 3/20 0.40
ATM Q13315 3/20 0.37
GRIN1 Q05586 2/20 0.36
GRIN2B Q13224 2/20 0.36
GAA P10253 1/20 0.35
HRH4 Q9H3N8 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34
ESR1 P03372 1/20 0.34
ESR2 Q92731 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
MEN1 O00255 1/20 0.33
CYP1A2 P05177 1/20 0.33
KMT2A Q03164 1/20 0.33
USP7 Q93009 1/20 0.33
TLR9 Q9NR96 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6879701 0.92 KDM1A (0.41) KDM1AATMGRIN1GRIN2BHRH4
Trifluoroacetic Acid SCHEMBL6875842 0.92 KDM1A (0.41) KDM1AATMGRIN1GRIN2BHRH4
SCHEMBL14082415 0.86 MAOA (0.42) GRIN1GRIN2BESR1ESR2MAOA
SCHEMBL4866443 0.80 EPHX1 (0.37) ATMMAOAMAOBMEN1CYP1A2
SCHEMBL24529835 0.74 HTR2C (0.56) HRH4HRH3MAOAMAOBMEN1
Bromide SCHEMBL6874908 0.74 NR1H2 (0.35) KDM1AGRIN1GRIN2BESR2MAOA
Bromide SCHEMBL6881930 0.74 NR1H2 (0.35) KDM1AGRIN1GRIN2BESR2MAOA
SCHEMBL14082453 0.73 KDM1A (0.43) KDM1AGRIN1GRIN2BESR1ESR2
SCHEMBL11554712 0.73 NR1H2 (0.48) GRIN1GRIN2BESR1ESR2NPC1
SCHEMBL9406360 0.73 NR1H2 (0.48) GRIN1GRIN2BESR1ESR2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7408067-B2 Aza-cyclic compounds as modulators of acetylcholine receptors MERCK + CO., INC. (US) 2008-08-05 US disclosed
US-20050070520-A1 Aza-cyclic compounds as modulators of acetylcholine receptors MERCK SHARP & DOHME CORP. 2005-03-31 US disclosed
EP-1467986-A1 AZA-CYCLIC COMPOUNDS AS MODULATORS OF ACETYLCHOLINE RECEPTORS ELI LILLY AND COMPANY (US) 2004-10-20 EP disclosed
WO-2003062224-A1 AZA-CYCLIC COMPOUNDS AS MODULATORS OF ACETYLCHOLINE RECEPTORS ELI LILLY AND COMPANY (US) 2003-07-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070520-A1 Aza-cyclic compounds as modulators of acetylcholine receptors CHRNG, CHRNA4, CHRNB4 KDM1A 1954/4885ATM 2976/4885GRIN1 266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.